Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a

E P Navarese1, S De Servi, C Michael Gibson

  • 1Institute of Cardiology, Catholic University of the Sacred Heart, Rome. eliano.navarese@alice.it

Insights

For non-ST-segment elevation acute coronary syndromes (NSTE-ACS), an early invasive strategy does not significantly improve survival or reduce myocardial infarction (MI) rates compared to a delayed approach. This meta-analysis found no significant benefit for early percutaneous coronary intervention in NSTE-ACS patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Early percutaneous coronary intervention (PCI) is standard for acute coronary syndromes.
  • Conflicting data exist regarding the optimal timing of PCI in non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
  • Determining the ideal invasive strategy is crucial for patient outcomes.

Purpose of the Study:

  • To conduct a meta-analysis of randomized controlled trials (RCTs).
  • To compare early versus delayed invasive strategies for NSTE-ACS patients.
  • To evaluate the impact on mortality, myocardial infarction (MI), revascularization, and bleeding complications.

Main Methods:

  • Searched Medline/CENTRAL and the Web for relevant RCTs.
  • Included 5 RCTs with a total of 4155 patients.
  • Utilized fixed or random effects models, including Bayesian meta-analysis for sensitivity analysis.

Main Results:

  • An early invasive approach did not significantly reduce all-cause mortality (OR 0.81, P=0.17).
  • Rates of myocardial infarction (MI) (OR 1.18, P=0.55) and revascularizations (OR 0.97, P=0.82) were not significantly improved.
  • A non-significant trend towards fewer major bleeding complications was observed with the early strategy (OR 0.76, P=0.08).

Conclusions:

  • A routine early invasive strategy does not significantly improve survival in NSTE-ACS patients compared to a delayed approach.
  • Early PCI did not lead to significant reductions in MI or revascularization rates.
  • The optimal timing for invasive strategies in NSTE-ACS requires further investigation.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...